Q3 Earnings Buzz: Recent chatter on X about Salesforce (CRM) has been lively following the company’s Q3 FY26 earnings report, which showed an 8.63% year-over-year revenue increase to $10.26 billion. Many are highlighting the stock’s 5% surge post-earnings, with discussions focusing on strong AI-driven growth through platforms like Agentforce. There’s a sense of renewed confidence among investors as Wall Street remains bullish.
Analyst Adjustments: Conversations on X also note a recent adjustment by a major financial institution, which lowered its price target for CRM from $405 to $398 while maintaining an optimistic rating. Some users question if this signals caution despite the positive earnings, while others see it as a minor recalibration. The mix of reactions keeps the debate engaging and dynamic.
AI Strategy Concerns: Amid the earnings hype, posts on X reveal skepticism about Salesforce’s long-term AI strategy and its ability to sustain growth in a competitive market. While some praise the company’s innovation, others worry about broader enterprise challenges impacting future performance. This tension adds depth to the ongoing discussion.
Note: This discussion summary was generated from an AI condensation of post data.
Salesforce Insider Trading Activity
Salesforce insiders have traded $CRM stock on the open market 494 times in the past 6 months. Of those trades, 2 have been purchases and 492 have been sales.
Here’s a breakdown of recent trading of $CRM stock by insiders over the last 6 months:
- MARC BENIOFF (Chair and CEO) has made 0 purchases and 479 sales selling 195,872 shares for an estimated $49,201,838.
- PARKER HARRIS (Co-Founder and CTO, Slack) has made 0 purchases and 7 sales selling 135,804 shares for an estimated $31,904,632.
- G MASON MORFIT purchased 96,000 shares for an estimated $25,015,680
- DAVID BLAIR KIRK purchased 3,400 shares for an estimated $865,827
- SRINIVAS TALLAPRAGADA (Chief Eng/Cust Success Officer) has made 0 purchases and 2 sales selling 1,269 shares for an estimated $332,919.
- SABASTIAN NILES (President and CLO) sold 569 shares for an estimated $149,275
- MIGUEL MILANO (President and CRO) sold 405 shares for an estimated $106,250
- SUNDEEP G. REDDY (EVP & Chief Accounting Officer) has made 0 purchases and 2 sales selling 261 shares for an estimated $68,472.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Salesforce Revenue
Salesforce had revenues of $10.3B in Q3 2026. This is an increase of 8.63% from the same period in the prior year.
You can track CRM financials on Quiver Quantitative's CRM stock page.
Salesforce Congressional Stock Trading
Members of Congress have traded $CRM stock 11 times in the past 6 months. Of those trades, 5 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $CRM stock by members of Congress over the last 6 months:
- SENATOR JOHN BOOZMAN sold up to $15,000 on 11/13.
- REPRESENTATIVE VAL T. HOYLE has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/26 and 1 sale worth up to $15,000 on 09/23.
- REPRESENTATIVE DAVID TAYLOR has traded it 3 times. They made 3 purchases worth up to $45,000 on 09/03, 08/07, 06/11 and 0 sales.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 06/17 and 2 sales worth up to $30,000 on 07/16.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE JAMES COMER sold up to $15,000 on 07/03.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Salesforce Hedge Fund Activity
We have seen 1,339 institutional investors add shares of Salesforce stock to their portfolio, and 1,666 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS added 10,636,161 shares (+159.0%) to their portfolio in Q3 2025, for an estimated $2,520,770,157
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 6,395,250 shares (+60.8%) to their portfolio in Q3 2025, for an estimated $1,515,674,250
- WELLINGTON MANAGEMENT GROUP LLP removed 5,283,162 shares (-85.2%) from their portfolio in Q3 2025, for an estimated $1,252,109,394
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 4,803,672 shares (+698.2%) to their portfolio in Q3 2025, for an estimated $1,138,470,264
- JPMORGAN CHASE & CO removed 4,771,344 shares (-26.8%) from their portfolio in Q3 2025, for an estimated $1,130,808,528
- HARRIS ASSOCIATES L P added 4,053,994 shares (+135.5%) to their portfolio in Q3 2025, for an estimated $960,796,578
- FRANKLIN RESOURCES INC removed 3,808,568 shares (-54.2%) from their portfolio in Q3 2025, for an estimated $902,630,616
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Salesforce Analyst Ratings
Wall Street analysts have issued reports on $CRM in the last several months. We have seen 13 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 12/04/2025
- Baird issued a "Outperform" rating on 12/04/2025
- Needham issued a "Buy" rating on 12/04/2025
- BMO Capital issued a "Outperform" rating on 12/04/2025
- Wedbush issued a "Outperform" rating on 12/04/2025
- Oppenheimer issued a "Outperform" rating on 12/01/2025
- Cantor Fitzgerald issued a "Overweight" rating on 11/25/2025
To track analyst ratings and price targets for Salesforce, check out Quiver Quantitative's $CRM forecast page.
Salesforce Price Targets
Multiple analysts have issued price targets for $CRM recently. We have seen 29 analysts offer price targets for $CRM in the last 6 months, with a median target of $315.0.
Here are some recent targets:
- Keith Weiss from Morgan Stanley set a target price of $398.0 on 12/09/2025
- Tyler Radke from Citigroup set a target price of $257.0 on 12/08/2025
- Gil Luria from DA Davidson set a target price of $235.0 on 12/05/2025
- Nehal Chokshi from Northland Capital Markets set a target price of $267.0 on 12/04/2025
- Scott Berg from Needham set a target price of $400.0 on 12/04/2025
- Rob Oliver from Baird set a target price of $315.0 on 12/04/2025
- Raimo Lenschow from Barclays set a target price of $330.0 on 12/04/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
